Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure

Li-Yuan Wang1, Qing-Hua Meng, Zhi-Qiang Zou

  • 1Department of Hepatology, Qilu Hospital of Shandong University, Wenhuaxi Road 107#, 250012 Jinan, China.

Insights

T helper 17 (Th17) cells and IL-17 are elevated in acute-on-chronic hepatitis B liver failure (ACHBLF). Higher Th17 cell levels correlate with disease severity and predict a poorer prognosis in ACHBLF patients.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • T helper 17 (Th17) cells are implicated in liver disease pathogenesis.
  • The specific role of Th17 cells in acute-on-chronic hepatitis B liver failure (ACHBLF) requires further elucidation.

Purpose of the Study:

  • To characterize circulating Th17 cells in ACHBLF patients.
  • To investigate the association between Th17 cells and disease progression in ACHBLF.

Main Methods:

  • Retrospective study involving 40 ACHBLF patients, 40 chronic hepatitis B (CHB) patients, and 20 healthy controls.
  • Quantification of peripheral Th17 cell frequency using flow cytometry.
  • Measurement of IL-17 mRNA levels in peripheral blood mononuclear cells (PBMCs) via quantitative real-time PCR.

Main Results:

  • Significantly increased Th17 cell frequency and IL-17 mRNA levels in ACHBLF patients compared to CHB patients and healthy controls.
  • In ACHBLF, Th17 cell frequency positively correlated with serum total bilirubin and MELD scores, and negatively with prothrombin activity.
  • Elevated Th17 cell frequency and IL-17 mRNA levels were observed in non-survivors versus survivors of ACHBLF.

Conclusions:

  • Th17 cells and IL-17 may be associated with disease severity in ACHBLF.
  • Th17 cells and IL-17 levels could serve as indicators of prognosis in ACHBLF patients.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...